67
Participants
Start Date
October 10, 2014
Primary Completion Date
October 18, 2017
Study Completion Date
October 18, 2017
Albiglutide weekly injection
Albiglutide will be provided as a fixed-dose, fully disposable pen injector system having a prefilled dual chamber glass cartridge. To be self-administered as a subcutaneous (SC) injection in the abdomen, thigh or upper arm region. The pen will deliver either 30 mg of albiglutide, 50 mg of albiglutide in a 0.5-mL injection volume. It may be administered at any time of day without regard to meals. It will be administered once a week on the same day each week
Placebo weekly injection
Placebo provided as a fixed-dose, fully disposable pen injector system having a prefilled dual chamber glass cartridge. To be self-administered as a SC injection in the abdomen, thigh or upper arm region. It may be administered at any time of day, once a week on the same day each week, without regard to meals.
Insulin
Commercially available basal/bolus insulin regimen, self administered by the subject, in accordance to the prescription of the physician and as per the package insert
GSK Investigational Site, Caen
GSK Investigational Site, Granada
GSK Investigational Site, Milan
GSK Investigational Site, Lleida
GSK Investigational Site, Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Düsseldorf
GSK Investigational Site, Seville
GSK Investigational Site, Alzira/Valencia
GSK Investigational Site, Lille
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Bois-Guillaume
GSK Investigational Site, Munich
GSK Investigational Site, Dresden
GSK Investigational Site, Latina
GSK Investigational Site, Roma
GSK Investigational Site, Badalona
GSK Investigational Site, Barcelona
GSK Investigational Site, L'Hospitalet de Llobregat
GSK Investigational Site, Pama de Mallorca
GSK Investigational Site, San Juan (Alicante)
GSK Investigational Site, Birmingham
GSK Investigational Site, Bristol
GSK Investigational Site, Cardiff
GSK Investigational Site, Darlington
GSK Investigational Site, Dundee
GSK Investigational Site, Durham
GSK Investigational Site, Glasgow
GSK Investigational Site, Liverpool
GSK Investigational Site, London
GSK Investigational Site, Newcastle upon Tyne
GSK Investigational Site, Sheffield
Lead Sponsor
GlaxoSmithKline
INDUSTRY